The future of the Bay Area biotech firm Allakos was riding on one clinical trial, for a drug designed to treat the skin ...

SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...

A serial entrepreneur and a promising drug emerge from failed companies to pursue subsets of obesity patients, with or ...

Exelixis (EXEL) has recently gained traction in the rapidly growing oncology market with its promising pipeline and strong ...

Metsera Inc. is seeking to raise $292 million in an initial public offering, joining a clutch of health-care firms set to ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Discover the top-performing biotech stocks in 2024! From oncology to psychedelics some companies showed remarkable results.

Shares of Trinity Biotech climbed after the company released what it called compelling results from a study of its next-generation continuous glucose monitoring system, a device used for diabetes ...

After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...

But what exactly is driving this sudden attention towards Trinity Biotech, and how does it compare to broader market trends? Let’s explore. Trinity Biotech is a commercial-stage biotechnology company ...

Last year was a surprisingly big one for legal decisions impacting the biotechnology transactions and licensing space. Given ...